文献速递主动脉疾病

TEVAR时机对急性B型主动脉壁内血肿主动脉重塑的影响

Impact of thoracic endovascular aortic repair timing on aortic remodeling in acute type B aortic intramural hematoma.
PubMed 文献 · J Vasc Surg · 2021-09-08

该回顾性研究纳入2008年至2018年因急性B型主动脉壁内血肿接受TEVAR的71例患者,比较24小时内急诊TEVAR(25例)与延迟TEVAR(46例,中位5.5天)的术后主动脉重塑。

要点

  • 延迟TEVAR组术后TAD/TLD比值更接近1.0,主动脉重塑更完全。
  • 急诊TEVAR组12个月主动脉相关不良事件发生率更高(24.0% vs 4.3%)。
  • 术后TAD/TLD比值是晚期主动脉相关不良事件的最佳预测指标(AUC=0.825)。

核心结论

  • 入院24小时内行TEVAR与较低的主动脉重塑程度和较高的晚期主动脉相关不良事件相关。
  • 临床条件允许时延迟TEVAR可能改善主动脉重塑和主动脉相关结局。

研究设计与样本

  • 回顾性病历回顾研究,纳入2008年1月至2018年9月因急性B型主动脉壁内血肿接受TEVAR的71例患者。
  • 急诊TEVAR组25例(24小时内),延迟TEVAR组46例(中位5.5天,范围2-120天)。
  • 主要终点为TAD/TLD比值最接近1.0的主动脉重塑,次要终点为12个月内主动脉相关不良事件和死亡。

主要发现

  • 急诊TEVAR组主动脉相关不良事件发生率为24.0%(6/25),延迟TEVAR组为4.3%(2/46)。

临床怎么用

  • 对急性B型主动脉壁内血肿患者,若临床条件允许,可考虑延迟TEVAR以改善主动脉重塑。
  • 术后TAD/TLD比值可用于预测晚期主动脉相关不良事件风险。
  • 急诊TEVAR患者基线降主动脉直径更大且穿透性主动脉溃疡更常见,需个体化评估。

局限性

  • 回顾性单中心研究,样本量有限(71例)。
  • 急诊与延迟TEVAR组基线特征存在差异(降主动脉直径和穿透性主动脉溃疡)。
  • 延迟TEVAR的时间范围较宽(2-120天),异质性较大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Thoracic endovascular aortic repair (TEVAR) is increasingly utilized in the management of acute type B aortic intramural hematoma (TBIMH). Optimal timing for intervention has not been described. The aim of this study was to evaluate TEVAR timing on postoperative aortic remodeling. METHODS: A retrospective chart review was performed on patients who underwent TEVAR for TBIMH from January 2008 to September 2018. Imaging was reviewed pre- and postoperatively. Primary data points included true lumen diameter (TLD) and total aortic diameter (TAD) at the site of maximal pathology. Primary endpoint was aortic remodeling evidenced by a TAD/TLD ratio closest to 1.0. Secondary outcome was occurrence of aortic-related adverse events and mortality (AREM): aortic rupture, aortic-related death, progression to dissection, or need for aortic reintervention within 12 months. Patients undergoing emergent TEVAR (within 24 hours, 'eTEVAR') were compared with the remainder - delayed TEVAR ('dTEVAR'). RESULTS: We analyzed 71 patients that underwent TEVAR for TBIMH; 25 underwent emergent TEVAR and 46 patients underwent dTEVAR (median, 5.5 days; range, 2-120 days). There were no differences in demographics and comorbidities, and patients did not differ in presenting IMH thickness (12.6 ± 3.1 vs 11.3 ± 4.1 mm; P = .186) nor presenting TAD/TLD ratio (1.535 ± 0.471 vs 1.525 ± 0.397; P = .928) for eTEVAR and dTEVAR groups, respectively. eTEVAR patients had larger average presenting maximal descending aortic diameter (45.8 ± 14.3 vs 38.2 ± 7.5 mm; P = .018) and higher incidence of penetrating aortic ulcer on presenting computed tomography angiography (52.0% vs 21.7%; P = .033). Thirty-day mortality was 2 of 25 (8.0%) for eTEVAR and 2 of 45 (4.4%) for dTEVAR (P = .602). Postoperative aortic remodeling was more complete in the dTEVAR group (1.23 ± 0.12 vs 1.33 ± 0.15; P = .004). Case-control matching (controlling for presenting descending aortic diameter and penetrating aortic ulcer) on 30 patients still showed better aortic remodeling in the dTEVAR group (1.125 ± 0.100 vs 1.348 ± 0.42; P < .001). The incidence of AREM was higher in the eTEVAR (6/25; 24.0%) group compared with the dTEVAR group (2/46; 4.3%). At 12 months, freedom from AREM was higher in the dTEVAR group (95.7% vs 76.0%; P = .011). Postoperative TAD/TLD ratio was the best predictor for late aortic-related adverse events (area under the receiver operator characteristic = 0.825; P = .003). CONCLUSIONS: TEVAR for acute TBIMH within 24 hours of admission is associated with lower aortic remodeling and higher occurrence of late AREM. Delaying TEVAR when clinically possible could improve aortic remodeling and aortic-related outcomes.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mesar T, Alie-Cusson FS, Lin MJ, et al. Impact of thoracic endovascular aortic repair timing on aortic remodeling in acute type B aortic intramural hematoma. J Vasc Surg. 2021. PMID: 34506888. doi:10.1016/j.jvs.2021.08.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。